Outsourcing in Regulated Work: When a CRO Beats Building In-House

Every business that grows beyond its founder eventually runs the same calculation. There is work that has to get done, nobody on staff can do it well, and the choice is between hiring someone who can and paying an outside firm that already does. Most of the time the stakes are low enough that the decision gets made on price and instinct.

Regulated industries don’t get that option. When a diagnostics company decides whether to build a clinical affairs function or contract with a CRO, a wrong answer does not show up as a slightly worse quarter. It shows up a year later as a submission the FDA sends back. That pressure has forced regulated sectors to think about build-versus-buy more rigorously than most other industries have, and the reasoning they have landed on works just as well for deciding who should be handling your inbox or your books.

The overall direction is already visible in the data. Deloitte’s 2024 Global Outsourcing Survey gathered responses from more than 500 business and technology leaders and found that 80% of executives plan to maintain or increase their spending with third-party providers, with skilled talent and agility now alongside cost reduction as primary drivers. Companies are no longer outsourcing only the work they consider beneath them. Increasingly, they outsource the work they cannot staff.

Start With Frequency, Not Price

The first question is not what a provider charges. It is how many hours a year the work genuinely exists.

A full-time hire is a standing commitment: salary, benefits, payroll taxes, equipment, management attention, and the recruiting spend that got the person through the door in the first place. SHRM’s benchmarking data on recruitment cost puts the average cost per hire at nearly $4,700 before anyone has completed a day of work, and talent management specialists cited alongside it estimate that the all-in cost of bringing on an employee can reach three to four times the salary of the position once soft costs such as manager and interviewer time are counted. Those figures are straightforward to justify for a role that runs at capacity fifty weeks a year. They are much harder to justify for a role with eight weeks of actual work.

Specialist compliance and analytical work is frequently that shape. A biostatistician is indispensable while a study protocol is being written and largely idle for the year that follows. A regulatory affairs lead matters enormously in the months around a submission and much less between them. Hiring for the peak means paying through the trough, and it also means the peak tends to arrive before the new hire is fully productive, because recruiting a narrow specialist takes longer than filling a generalist role and the work does not wait for the search to close.

Project-based engagements with a defined endpoint are the structural alternative, and they are typically priced as a fixed bid rather than an hourly rate, thereby converting an open-ended payroll commitment into a known number tied to a deliverable. The trade-off is real, since you give up the accumulated context an employee builds over years. For work that recurs rarely, though, that context was never going to accumulate in the first place.

What Regulated Work Makes Visible

Regulated work is a useful test case because it makes the cost of a bad decision legible. Consider what an in vitro diagnostics developer has to settle before collecting a single patient sample. The intended use statement drives the study population, the comparator, the endpoints, and often the regulatory pathway itself. Sample size depends on expected disease prevalence, anticipated sensitivity and specificity, target confidence intervals, and an acceptable margin of error, all of which must be fixed in the protocol before enrollment opens rather than settled once the data start to tell a story. These are clinical validation study design decisions, and an error in any one of them usually surfaces months later as a regulator asking for data the study was never built to produce.

That is the shape of the problem in any regulated function. The expensive mistakes are not visible in the work product at the time of delivery. A payroll filing that is wrong in a way nobody notices until an audit, a privacy notice that does not match what the software actually collects, a clinical protocol with an endpoint that was never locked down: all of these read as finished work right up until they do not. Where errors are silent and deferred, experience is worth considerably more than availability, and experience is precisely what an established specialist firm has, and a first hire does not.

Delegating The Work Does Not Delegate The Responsibility

The strongest argument against outsourcing is also the one most often misunderstood. Handing work to an outside provider does not move the consequences of that work off your books.

United States drug regulation states this outright. A sponsor may transfer responsibility for any or all of its obligations to a contract research organization, but the transfer has to be described in writing, and obligations not covered by the written description are deemed never to have been transferred at all. The CRO becomes answerable for what it explicitly assumed. Everything else stays with the sponsor, whether or not the sponsor realized it was still holding it.

The principle scales down without losing any force. If a bookkeeper misfiles, the penalty letter arrives at your address. If a contractor mishandles customer data, the notification obligation is yours. The written agreement is where responsibility actually gets allocated, which is why the terms a working agreement should specify, including services and deliverables, availability, confidentiality, ownership of work product, and notice periods for ending the engagement, deserve more attention than the hourly rate does. Anything the agreement does not name, you keep by default.

The practical implication is that outsourcing never eliminates the need for judgment on your part in the relationship. You still have to be able to evaluate the output. A sponsor who cannot distinguish a well-powered study from an underpowered one cannot meaningfully supervise a CRO, and a business owner who has never reconciled a bank statement will not catch a bookkeeper who quietly stops reconciling. Buying expertise reduces the amount of expertise you need to hold internally. It does not reduce it to zero.

When Building In-House Is The Right Call

The case for hiring turns on three things, and price is not one of them.

The first is frequency. Work that is continuous and predictable rewards a permanent hire because the fixed costs of recruiting and onboarding are amortized over years rather than weeks. The second is proximity to the core of the business. Anything that constitutes your actual competitive advantage belongs inside, because an outside provider who builds that capability for you can rebuild it for anyone else. The third is the value of accumulated context. Some roles are worth far more in year three than in year one because the person has absorbed how the organization actually works, who decides what, and where the recurring problems live. That gain is real, and it is forfeited every time an engagement ends.

Most regulated companies end up running a hybrid for exactly these reasons. A small internal team owns strategy, holds the institutional memory, and can judge outside work, while contracted specialists are brought in for the peaks. Nobody staffs internally for a workload that appears once every three years, and nobody outsources the judgment about whether the resulting work is any good.

Four Questions Before You Decide

The framework translates across industries because it does not depend on the subject matter. How many hours a year does the work actually exist? Below roughly half a full-time load, a permanent hire is difficult to justify on economics alone. What happens if the work is done badly, and when would you find out? Errors that surface immediately are cheap to correct, while errors that surface at an audit or a regulatory review are not, which argues for buying experience rather than developing it on the job. Can you evaluate the output? If the answer is no, that gap needs to be closed before you delegate, not after. And what stays with you regardless of who does the work? More than the agreement says, so read the agreement closely and assume the residue is yours.

Regulated work is only useful here as the extreme case. It forces the same four questions that a smaller business can usually afford to answer loosely, which is exactly why answering them deliberately is worth the effort at any scale.